157 related articles for article (PubMed ID: 17393309)
1. Failures in a proton pump inhibitor therapeutic substitution program: lessons learned.
Lu M; Malladi V; Agha A; Abudayyeh S; Han C; Siepman N; Graham DY
Dig Dis Sci; 2007 Oct; 52(10):2813-20. PubMed ID: 17393309
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
Çelebi A; Aydın D; Kocaman O; Konduk BT; Şentürk Ö; Hülagü S
Turk J Gastroenterol; 2016 Sep; 27(5):408-414. PubMed ID: 27782887
[TBL] [Abstract][Full Text] [Related]
3. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
Hall J; Dodd S; Durkin M; Sloan S
Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.
Kusano M; Shimoyama Y; Kawamura O; Maeda M; Kuribayashi S; Nagoshi A; Zai H; Moki F; Horikoshi T; Toki M; Sugimoto S; Mori M
Dig Dis Sci; 2007 Jul; 52(7):1673-7. PubMed ID: 17385034
[TBL] [Abstract][Full Text] [Related]
5. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
Röhss K; Lind T; Wilder-Smith C
Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
[TBL] [Abstract][Full Text] [Related]
6. [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].
Maev IV; Balashova NN; Busarova GA
Klin Med (Mosk); 2003; 81(9):54-9. PubMed ID: 14598594
[TBL] [Abstract][Full Text] [Related]
7. Scoring of reflux symptoms associated with scleroderma and the usefulness of rabeprazole.
Muro Y; Sugiura K; Nitta Y; Mitsuma T; Hoshino K; Usuda T; Hayashi K; Murase Y; Shimizu M; Matsuo H
Clin Exp Rheumatol; 2009; 27(3 Suppl 54):15-21. PubMed ID: 19796556
[TBL] [Abstract][Full Text] [Related]
8. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
[TBL] [Abstract][Full Text] [Related]
9. Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions.
Kivioja A; Linnosmaa I; Vehviläinen A; Vohlonen I
Eur J Pharm Sci; 2004 Feb; 21(2-3):171-8. PubMed ID: 14757488
[TBL] [Abstract][Full Text] [Related]
10. Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: a randomized crossover study.
Hata S; Arai M; Maruoka D; Tanaka T; Matsumura T; Suzuki T; Nakagawa T; Katsuno T; Imazeki F; Yokosuka O
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):296-301. PubMed ID: 22959094
[TBL] [Abstract][Full Text] [Related]
11. Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease.
Lee YC; Lin JT; Wang HP; Chiu HM; Wu MS
J Gastroenterol Hepatol; 2007 Aug; 22(8):1286-92. PubMed ID: 17559380
[TBL] [Abstract][Full Text] [Related]
12. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Poe RH; Kallay MC
Chest; 2003 Mar; 123(3):679-84. PubMed ID: 12628862
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
[TBL] [Abstract][Full Text] [Related]
14. Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?
Zhou Q; Yan XF; Pan WS; Zeng S
World J Gastroenterol; 2008 Apr; 14(16):2617-9. PubMed ID: 18442220
[TBL] [Abstract][Full Text] [Related]
15. [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].
Mullner K; Molnar B; Tulassay Z
Orv Hetil; 2007 Mar; 148(12):543-51. PubMed ID: 17444020
[TBL] [Abstract][Full Text] [Related]
16. Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole.
Damiano A; Siddique R; Xu X; Johanson J; Sloan S
Dig Dis Sci; 2003 Apr; 48(4):657-62. PubMed ID: 12741452
[TBL] [Abstract][Full Text] [Related]
17. Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center.
Coté GA; Ferreira MR; Rozenberg-Ben-Dror K; Howden CW
Aliment Pharmacol Ther; 2007 Mar; 25(6):709-14. PubMed ID: 17311604
[TBL] [Abstract][Full Text] [Related]
18. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
[TBL] [Abstract][Full Text] [Related]
19. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
[TBL] [Abstract][Full Text] [Related]
20. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
Littner MR; Leung FW; Ballard ED; Huang B; Samra NK;
Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]